Adverse drug reactions in current antihypertensive therapy: A general practice survey of 2586 patients in Norway

Blood Pressure

Volumn 8, Issue 2, 1999, Pages 94-101

  Olsen, Harald ^a,e   Klemetsrud, Trine ^a   Stokke, Hans Petter ^b   Tretli, Steinar ^c   Westheim, Arne ^d  

^a Diakonhjemmets Sykehus ^*  (Norway)

^b Nordsida Legekontor   (Norway)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d Medical Department B   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adverse drug reactions; Antihypertensives; Drugs

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; LOSARTAN; METHYLDOPA;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONSTIPATION; DEPRESSION; DIURESIS; EDEMA; FATIGUE; FEMALE; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; RASH; SEXUAL DYSFUNCTION; URINE INCONTINENCE; VERTIGO; XEROSTOMIA;

ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 0032797575     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370599438266     Document Type: Article

References (21)

1. Os I, Bratland B, Dahløf B, Gisholt K, Syvertsen JO, Tretli S. Lisinopril or nifedipine in essential hypertension? A Norwegian multicenter study of efficacy, tolerability and quality of life in 828 patients. J Hypertens 1991; 9: 1097-04.
2. Omvik P, Thaulow E, Herland OB, Eide I, Midha R, Turner RR. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study. J Hypertens 1993; 11: 103-13.
3. Rawlins MD. Postmarketing surveillance of adverse reactions to drugs. Br Med J 1984; 288: 879-80.
4. WHO Collaborating Centre for Drug Statistics Methodology Guidelines for ATC classification and DDD assignment. 1996, 1st edition. Oslo: Norsk Medisinaldepot AS.
5. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med 1980; 69: 725-32.
6. MRC Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97-104.
7. MRC Working Party. Medical Research Council trial of treatment of hypertension in old adults: principal results. Br Med J 1992; 304: 405-12.
8. Dahløf B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertensjon). Lancet 1991; 338: 1281-5.
9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991; 265: 3255-64.
10. Neaton JD, Grimm RH, Jr, Prineas RJ, Stamler J, et al. For the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study. Final results. JAMA 1993; 270: 713-24.
11. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. Br Med J 1995; 311: 293-5.
12. Lip GYH, Beevers DG. Doctors, Nurses, Pharmacists and Patients - the rational evaluation and choice in hypertension (REACH). Survey of hypertension care delivery. Blood Pressure 1997; 6 (Suppl 1): 6-10.
13. Borrild NJ. Patients' experiences of antihypertensive drugs in routine use: results of a Danish general practice survey. Blood Pressure 1997; 6 (Suppl 1): 23-25.
14. Goldberg AI, Dunlay MC, Sweet CS. Safety and Tolerability of Losartan Potassium, an Angiotensin II receptor antagonist, compared with Hydrochlorothiazide, Atenolol, Felodipine ER, and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Systemic Hypertension. Am J Cardiol 1995; 75: 793-95.
15. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-83.
16. Croog SH, Levine S, Testa MA, Brown B, Bulbitt CJ, Jenkins CD, et al. The effect of antihypertensive therapy on quality of life. N Engl J Med 1986; 314: 1657-64.
17. Croog SH, Kong W, Levine S, Weir MR, Baume RM, Saunders E. Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Arch Int Med 1990; 150: 1733-41.
18. Carlsen JE, Køber L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect and adverse biochemical effects. Br Med J 1990; 300: 975-8.
19. Talseth T, Westlie L, Daae L. Doxazocin and atenolol as monotherapy in mild and moderate hypertension: A randomized, parallel study with a three-year follow-up. Am Heart J 1991; 121: 280-85.
20. Chalmers D, Whitehead A, Lawson DH. Postmarketing surveillance of captopril for hypertension. Br J Clin Pharmacol 1992; 34: 215-23.
21. Williamson J. Adverse reaction to pescribed drugs in elderly. In: Crooks J, Stewenson JH, editors. Drugs and elderly, perspectives in geriatric clinical pharmacology. Macmillan Press Ltd, London and Basingstoke 1979: 239-46.